Roche and Accenture will create a platform for diabetes management

It will integrate current and future products, solutions and services that connect diabetics with their caregivers and health suppliers and allow more personalized support.

Roche announced on Wednesday a collaboration agreement with Accenture, for which, for five years, they will develop a data platform interconnected with the pharmaceutical digital ecosystem, with the aim of changing the way in which diabetes care will be providedin the future.The new data platform will integrate current and future products, solutions and services that connect people with diabetes with their caregivers and health suppliers.This will allow Roche to offer more personalized, precise and complete support through a holistic management of the disease.

The data platform will be developed from the smart platform of Accenture.For this, the consultant will provide a tool that will allow Roche to gather data in a safe environment, generate the analytical keys necessary to conduct the future of diabetes therapies and easily integrate new solutions and devices.

"This collaboration agreement with Accenture is an outstanding advance and offers truly integrated diabetes management solutions," said Marcel Gmünder, head of Roche Diabetes Care.The Diabetes Platform that we are creating will allow us to analyze and contextualize a large amount of data through algorithms, responding faster to the needs of people with diabetes, their caregivers and health systems, personalizing the treatment to be able to direct it towards better results."Collaboration is based on a relationship of trust maintained over the years. This will allow usPatient care in the future, with the aim of improving the results of the therapy, the quality of life of people and the sustainability of health systems. "

Koen Deryckere, responsible for the product of Accenture in Europe, Africa, the East and Latin America, has stated: "We are delighted to carry our collaboration of trust with Roche to the next level, to revolutionize the care of patients with diabetes. This digital system basedOn the smart patient platform of Accenture, it will combine Roche's experience in diabetes with the experience in Accenture's life and health sciences, and will provide a safe and analytical environment to the health industry for better care of patients with patients withdiabetes".

Gather data ??To make a database (of all people) and sell them to the highest bidder and then bombard us with calls, emails, SMS, etc ... but they have the jeta to say that it is to connect the diabetics with their caregivers (The visit to the endocrine is made by videoconference :))).They want to sell a futurism that is today with glucometers, bombs, feathers, insulins, etc. is ridiculous.It is better that they will focus on perfecting their customer service platform, which is what the diabetic patient of these people has when their wonderful products fail, because coincidences of life turn it is that it is from the customer service department of all these wonderfulLaboratories that create and look with futuristic increases for diabetics who leave much to be desired due to ineptitude, ignorance and slowness to manage, solve and give quick solution to problems, because we remember that when a device of these people fails, thehealth of that person.That begin to perfect and give quality in the production/manufacture of their products.

It reminds me of when I started making websites for companies 20 years ago and they didn't know what to put, we wrote the same empty talk:
"Creation of management platforms.
"Integration of current and future products, solutions and services that connect with their suppliers and will allow more personalized support ...".:-@

What a charlatans these from Roche and Accenture.

PFFF, and who will read and manage all those data.

We better help each other in a forum like this.;)